Investigating genetic variations in the complement system related to age-related macular degeneration.

Functional Analysis of Complement Variants in a Genotyped iPSC Epithelial Cell Model System

NIH-funded research University of Pennsylvania · NIH-10994169

This study is looking at how genetic differences in a part of the immune system affect the health of eye cells in people with age-related macular degeneration, using special cells from patients to learn more about how these differences might impact eye function and lead to new treatments.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania NIH-funded
Lab location1 site (Philadelphia, United States)
Project IDNIH-10994169 on NIH RePORTER

What this research studies

This research focuses on understanding how genetic variations in the complement system affect the response of retinal pigment epithelial cells, which are crucial for eye health. Using induced pluripotent stem cells (iPSCs) from patients with intermediate age-related macular degeneration, the researchers will differentiate these cells into retinal pigment epithelial cells and analyze their function. The study aims to quantify the levels of complement proteins and assess how genetic differences influence their production and activity. This could provide insights into the mechanisms behind age-related macular degeneration and potential therapeutic targets.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with intermediate age-related macular degeneration, particularly those with specific genetic variations.

Not a fit: Patients without age-related macular degeneration or those with other unrelated eye conditions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating age-related macular degeneration.

How similar studies have performed: Previous research has shown promising results in understanding the role of genetic variations in the complement system, suggesting that this approach could yield valuable insights.

Where this research is happening

Philadelphia, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions age related macular disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.